Codiak BioSciences' GAAP loss for 9M 2021 was $53.819 million, down 27% from $73.708 million in the previous year. Revenue increased 12-fold to $15.238 million from $1.275 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept